Related Experiment Video
Updated: Feb 18, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Quantitative chemoproteomic profiling reveals multiple target interactions of spongiolactone derivatives in leukemia
M H Wright1, Y Tao, J Drechsel
1Center for Integrated Protein Science (CIPSM), Department of Chemistry, Technical University of Munich, Lichtenbergstr. 4, D-85748, Garching, Germany. stephan.sieber@mytum.de.
Abstract:
The spongiolactones are marine natural products with an unusual rearranged spongiane skeleton and a fused β-lactone ring. These compounds have potential anticancer properties but their mode of action has yet to be explored. Here we employ activity-based protein profiling to identify the targets of a more potent spongiolactone derivative in live cancer cells, and compare these to the targets of a simpler β-lactone. These hits provide the first insights into the covalent mechanism of action of this natural product class.

